Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)

NCT03184935 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Others

Conditions

Myelodysplastic Syndromes

Interventions

BIOLOGICAL: Allogeneic umbilical cord mesenchymal stem cells
DRUG: Decitabine

Sponsor

Sclnow Biotechnology Co., Ltd.